甲状腺功能减退症的新型因果血浆蛋白:大规模血浆蛋白质组孟德尔随机化分析

Novel Causal Plasma Proteins for Hypothyroidism: A Large-scale Plasma Proteome Mendelian Randomization Analysis.

作者信息

Yang Hongqun, Chen Lanlan, Liu Yahui

机构信息

Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, First hospital of Jilin University, Changchun 130021, China.

出版信息

J Clin Endocrinol Metab. 2023 Jan 17;108(2):433-442. doi: 10.1210/clinem/dgac575.

Abstract

CONTEXT

Although several risk proteins for hypothyroidism have been reported in recent years, many more plasma proteins have not been tested.

OBJECTIVE

To determine potential mechanisms and novel causal plasma proteins for hypothyroidism using Mendelian randomization (MR).

METHODS

A large-scale plasma proteome MR analysis was conducted using protein quantitative trait loci (pQTLs) for 2297 plasma proteins. We classified pQTLs into 4 different groups. MR analyses were conducted within the 4 groups simultaneously. Significant proteins were discovered and validated in 2 different cohorts. Colocalization analysis and enrichment analysis were conducted using proteins found with MR.

RESULTS

Thirty-one proteins were identified in the discovery cohort. Among them, 13 were validated in the validation cohort. Nine of the 13 proteins are risk factors (ISG15, Fc receptor-like protein 2, tumor necrosis factor ligand superfamily member 14, Rab-2A, FcRL3, thrombomodulin, interferon [IFN]-lambda-1, platelet glycoprotein Ib alpha chain, IL-7RA) for hypothyroidism, whereas others are protective proteins (protein O-glucosyltransferase 1 [POGLUT1], tumor necrosis factor ligand superfamily, 3-hydroxyisobutyryl-CoA hydrolase, transferrin receptor protein 1). Among the significant proteins, POGLUT1 strongly colocalized with expression quantitative trait loci from whole blood (posterior probability of colocalization [PP4] = 0.978) and the thyroid (PP4 = 0.978). Two different trans-pQTLs (rs2111485 PP4 = 0.998; rs35103715 PP4 = 0.998) for IFN-lambda-1 strongly colocalized with hypothyroidism in different chromosomes.

CONCLUSION

Thirteen various proteins were identified and validated to be associated with hypothyroidism using univariable MR. We reinforced and expanded the effect of IFN on hypothyroidism. Several proteins identified in this study could explain part of the association between the coagulation system and hypothyroidism. Our study broadens the causal proteins for hypothyroidism and provides the relationships between plasma proteins and hypothyroidism. The proteins identified in this study can be used as early screening biomarkers for hypothyroidism.

摘要

背景

尽管近年来已报道了几种甲状腺功能减退的风险蛋白,但仍有更多血浆蛋白未经过检测。

目的

利用孟德尔随机化(MR)确定甲状腺功能减退的潜在机制和新的因果血浆蛋白。

方法

使用2297种血浆蛋白的蛋白质定量性状位点(pQTL)进行大规模血浆蛋白质组MR分析。我们将pQTL分为4个不同的组。在这4个组中同时进行MR分析。在2个不同队列中发现并验证了显著蛋白。使用通过MR发现的蛋白进行共定位分析和富集分析。

结果

在发现队列中鉴定出31种蛋白。其中,13种在验证队列中得到验证。这13种蛋白中有9种是甲状腺功能减退的风险因素(ISG15、Fc受体样蛋白2、肿瘤坏死因子配体超家族成员14、Rab-2A、FcRL3、血栓调节蛋白、干扰素[IFN]-λ-1、血小板糖蛋白Ibα链、IL-7RA),而其他的是保护蛋白(蛋白O-葡萄糖基转移酶1[POGLUT1]、肿瘤坏死因子配体超家族、3-羟基异丁酰辅酶A水解酶、转铁蛋白受体蛋白1)。在这些显著蛋白中,POGLUT1与全血(共定位后验概率[PP4]=0.978)和甲状腺(PP4=0.978)的表达定量性状位点强烈共定位。IFN-λ-1的两种不同的反式pQTL(rs2111485,PP4=0.998;rs35103715,PP4=0.998)在不同染色体上与甲状腺功能减退强烈共定位。

结论

使用单变量MR鉴定并验证了13种与甲状腺功能减退相关的不同蛋白。我们加强并扩展了IFN对甲状腺功能减退的影响。本研究中鉴定出的几种蛋白可以解释凝血系统与甲状腺功能减退之间关联的部分原因。我们的研究拓宽了甲状腺功能减退的因果蛋白范围,并提供了血浆蛋白与甲状腺功能减退之间的关系。本研究中鉴定出的蛋白可作为甲状腺功能减退的早期筛查生物标志物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索